Fibrin-Rhamnogalacturonan I Composite Gel for Therapeutic Enzyme Delivery to Intestinal Tumors

Therapy of colorectal cancer with protein drugs, including targeted therapy using monoclonal antibodies, requires the preservation of the drug’s structure and activity in the gastrointestinal tract or bloodstream. Here, we confirmed experimentally the fundamental possibility of creating composite pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Faizullin, Dzhigangir, Valiullina, Yuliya, Salnikov, Vadim, Zelenikhin, Pavel, Zuev, Yuriy, Ilinskaya, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862006/
https://www.ncbi.nlm.nih.gov/pubmed/36674440
http://dx.doi.org/10.3390/ijms24020926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862006/
https://www.ncbi.nlm.nih.gov/pubmed/36674440
http://dx.doi.org/10.3390/ijms24020926

Ejemplares similares